October 31, 2014– Interviewed by Steven E. Greer, MD
The portion of total Type 1 diabetes patients who use continuous glucose monitors (CGM) are still far less than 50%. We interviewed the CEO of Dexcom, Terry Gregg, with diabetes expert Jay Skyler, MD, from Miami, to discuss the clinical hurdles to prescribing CGM.
Disclaimer: Dr. Skyler has various relationships with Dexcom.